Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Julien Mazières; Claire Cropet; Laure Montané; Fabrice Barlési; P.-J. Souquet; Xavier Quantin; Catherine Dubos‐Arvis; Josiane Otto; Laure Favier; Virginie Avrillon; J. Cadranel; Denis Moro‐Sibilot; I. Monnet; Virginie Westeel; J. Le Treut; Étienne Brain; Jean Trédaniel; M. Jaffro; S. Collot; G. Ferretti; Céline Tiffon; Céline Mahier‐Ait Oukhatar; Jean Yves Blay

doi:10.1016/j.annonc.2019.10.022

Related publications

Article2022

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer

David S. Hong, Ajay K. Gopal, Alexander N. Shoushtari, Sandip Pravin Patel, Aiwu Ruth He, Toshihiko Doi, Suresh S. Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B. Davis, Timothy S. Fisher, Bo Huang, Kolette D. Fly, Antoni Ribas

Article2017

Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer

Hisato Kawakami, Junko Tanizaki, Kaoru Tanaka, Koji Haratani, Hidetoshi Hayashi, Masayuki Takeda, Ken Kamata, Mamoru Takenaka, Masatomo Kimura, Takaaki Chikugo, Takao Sato, Masatoshi Kudo, Akihiko Ito, Kazuhiko Nakagawa

Letter2007

ERCC1-Specific Immunostaining in Non–Small-Cell Lung Cancer

Ken A. Olaussen, Pierre Fouret, Guido Guido Kroemer

Article2018

Treating ALK-positive non-small cell lung cancer

Dimitrios C. Ziogas, Anna Tsiara, Georgios Tsironis, Maria Lykka, Michalis Liontos, Aristotelis Bamias, Meletios A Dimopoulos

Article2019

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Lévesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Déborah Lefevre, Sophie Broutin, Angélo Paci, ,